Zobrazeno 1 - 10
of 4 215
pro vyhledávání: '"RUBBERT ROTH, A"'
Autor:
Rubbert-Roth, Andrea1 (AUTHOR) andrea.rubbert-roth@kssg.ch, Kato, Koji2 (AUTHOR), Haraoui, Boulos3 (AUTHOR), Rischmueller, Maureen4,5 (AUTHOR), Liu, Yanxi2 (AUTHOR), Khan, Nasser2 (AUTHOR), Camp, Heidi S.2 (AUTHOR), Xavier, Ricardo M.6 (AUTHOR)
Publikováno v:
Rheumatology & Therapy. Oct2024, Vol. 11 Issue 5, p1197-1215. 19p.
Autor:
Andrea Rubbert-Roth, Koji Kato, Boulos Haraoui, Maureen Rischmueller, Yanxi Liu, Nasser Khan, Heidi S. Camp, Ricardo M. Xavier
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 5, Pp 1197-1215 (2024)
Abstract Introduction The safety and efficacy of upadacitinib 15 mg (UPA15) through week 216 was evaluated in patients with rheumatoid arthritis (RA) from the long-term extension (LTE) of the phase 3 SELECT-CHOICE study. Methods Patients with RA refr
Externí odkaz:
https://doaj.org/article/d313932347fc4677b9fb4fe93f411d0d
Autor:
Gerd R. Burmester, Jayne Stigler, Andrea Rubbert-Roth, Yoshiya Tanaka, Valderilio F. Azevedo, Derek Coombs, Ivan Lagunes, Ralph Lippe, Peter Wung, Lianne S. Gensler
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 3, Pp 737-753 (2024)
Abstract Introduction This integrated analysis of the phase 2/3 and phase 3 SELECT trials describes the safety profile of upadacitinib, an oral Janus kinase inhibitor, for up to 5 years of exposure across psoriatic arthritis (PsA), ankylosing spondyl
Externí odkaz:
https://doaj.org/article/e351d86bf89749d7bfde8d923d44f476
Autor:
Roy Fleischmann, Stephen Hall, Bernard Combe, Andrea Rubbert-Roth, Christina Charles-Schoeman, Nasser Khan, Heidi S Camp, Sebastian Meerwein, Kyle M Carter
Publikováno v:
RMD Open, Vol 10, Iss 3 (2024)
Objective To evaluate the efficacy and safety of upadacitinib over 5 years among patients with rheumatoid arthritis (RA) in a long-term extension (LTE) of the SELECT-BEYOND phase 3 trial.Methods Patients refractory to ≥1 biological disease-modifyin
Externí odkaz:
https://doaj.org/article/76db6d5729924754958a446387d0a992
Autor:
Rubbert-Roth, Andrea1 (AUTHOR) andrea.rubbert-roth@kssg.ch, Kakehasi, Adriana M.2 (AUTHOR), Takeuchi, Tsutomu3,4 (AUTHOR), Schmalzing, Marc5 (AUTHOR), Palac, Hannah6 (AUTHOR), Coombs, Derek6 (AUTHOR), Liu, Jianzhong6 (AUTHOR), Anyanwu, Samuel I.6 (AUTHOR), Lippe, Ralph7 (AUTHOR), Curtis, Jeffrey R.8 (AUTHOR)
Publikováno v:
Rheumatology & Therapy. Feb2024, Vol. 11 Issue 1, p97-112. 16p.
Autor:
Andrea Rubbert-Roth, Adriana M. Kakehasi, Tsutomu Takeuchi, Marc Schmalzing, Hannah Palac, Derek Coombs, Jianzhong Liu, Samuel I. Anyanwu, Ralph Lippe, Jeffrey R. Curtis
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 1, Pp 97-112 (2023)
Abstract Introduction This article aims to describe malignancies in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), or non-radiographic axial spondyloarthritis (nr-axSpA) treated with upadacitinib (UPA
Externí odkaz:
https://doaj.org/article/a4e890c38a81458f8f0e15e86b14da3d
Autor:
Rech, Juergen, Tascilar, Koray, Hagen, Melanie, Kleyer, Arnd, Manger, Bernhard, Schoenau, Verena, Hueber, Axel J, Kleinert, Stefan, Baraliakos, Xenofon, Braun, Jürgen, Kiltz, Uta, Fleck, Martin, Rubbert-Roth, Andrea, Kofler, David M, Behrens, Frank, Feuchtenberger, Martin, Zaenker, Michael, Voll, Reinhard, Venhoff, Nils, Thiel, Jens, Glaser, Cornelia, Feist, Eugen, Burmester, Gerd R, Karberg, Kirsten, Strunk, Johannes, Cañete, Juan D, Senolt, Ladislav, Filkova, Maria, Naredo, Esperanza, Largo, Raquel, Krönke, Gerhard, D'Agostino, Maria-Antonietta, Østergaard, Mikkel, Schett, Georg *
Publikováno v:
In The Lancet 2-8 March 2024 403(10429):850-859
Autor:
Oliver Distler, Diego Kyburz, Adrian Ciurea, Michael J Nissen, Andrea Rubbert-Roth, Raphael Micheroli, Almut Scherer, Kristina Bürki, Pascale Exer, Burkhard Möller, Michael Andor, René Bräm, Thomas Hügle, Andrea Götschi
Publikováno v:
RMD Open, Vol 9, Iss 4 (2023)
Objective To characterise the population fulfilling the Assessment of SpondyloArthritis international Society (ASAS) consensus definition of early axial spondyloarthritis (axSpA) and to determine the effectiveness of a first tumour necrosis factor in
Externí odkaz:
https://doaj.org/article/491c692f5c3b43538d8c9679b92355ac
Autor:
Frank Behrens, Jürgen Rech, Jürgen Braun, Denis Poddubnyy, Gerd R Burmester, Uta Kiltz, Stephanie Finzel, Diamant Thaçi, Herbert Kellner, Karolina Benesova, Reinhard E Voll, Jan Brandt, Andrea Rubbert-Roth, David M Kofler, Klaus Krüger, Siegfried Wassenberg, Winfried Demary, Regina Max, Peter Kastner, Michaela Koehm, Ulrich von Hinüber, Raoul Bergner, Jan Brandt-Jürgens, Ann C Foldenauer, Tanja Rossmanith, Maren Sieburg, Rieke HE Alten, Arnd Kleye, David Kofler, Gabriele Lorenz, Holger Schwenke, Astrid Thiele, Jochen Walter
Publikováno v:
RMD Open, Vol 9, Iss 4 (2023)
Background The influence of sex on treatment outcomes during interleukin-12/23 therapy in patients with psoriatic arthritis (PsA) has not been explored.Objective To conduct exploratory post hoc analyses of sex-stratified data from the MUST trial, an
Externí odkaz:
https://doaj.org/article/b3acb669834f448d9e33b145ffe10884
Autor:
Peter C. Taylor, Yun-Fei Chen, Janet Pope, Michael Weinblatt, Eduardo Mysler, Andrea Rubbert-Roth, Bochao Jia, Luna Sun, Yushi Liu, Thorsten Holzkämper, Yoshiya Tanaka
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 2, Pp 463-476 (2023)
Plain Language Summary Baricitinib is an oral agent widely approved for the treatment of moderately to severely active rheumatoid arthritis). Although baricitinib (and other agents) have demonstrated efficacy at the population level, treatment respon
Externí odkaz:
https://doaj.org/article/db973ae12e4040fbb0269c01ccf82ada